RxSight (RXST) Revenue (2020 - 2026)

RxSight (RXST) has 7 years of Revenue data on file, last reported at $30.9 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 18.48% year-over-year to $30.9 million; the trailing twelve-month figure through Mar 2026 stood at $127.5 million (down 14.05% YoY), and the FY2025 full-year result was $134.5 million, down 3.89% from the prior year.
• Revenue for Q1 2026 stood at $30.9 million, down from $32.6 million in the prior quarter.
• Across five years, Revenue topped out at $40.2 million in Q4 2024 and bottomed at $8.9 million in Q1 2022.
• The 5-year median for Revenue is $29.5 million (2024), against an average of $26.1 million.
• The widest annual swing landed in 2022, when Revenue surged 156.66%; it then decreased 18.91% in 2025.
• A 5-year view of Revenue shows it stood at $16.1 million in 2022, then soared by 77.65% to $28.6 million in 2023, then surged by 40.71% to $40.2 million in 2024, then slipped by 18.91% to $32.6 million in 2025, then fell by 5.26% to $30.9 million in 2026.
• The last three Revenue figures came in at $30.9 million (Q1 2026), $32.6 million (Q4 2025), and $30.3 million (Q3 2025), per Business Quant data.

Peer Comparison